tiprankstipranks
Amneal Pharmaceuticals Inc (AMRX)
NASDAQ:AMRX
US Market
AMRX
Amneal Pharmaceuticals
RESEARCH TOOLSreports
Want to see AMRX full AI Analyst Report?

Amneal Pharmaceuticals (AMRX) Income Statement

604 Followers

Amneal Pharmaceuticals Income Statement

Last quarter (Q4 2025), Amneal Pharmaceuticals's total revenue was $814.32M, an increase of 11.47% from the same quarter last year. In Q4, Amneal Pharmaceuticals's net income was $35.08M. See Amneal Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 3.02B$ 2.79B$ 2.39B$ 2.21B$ 2.09B
Gross Profit
$ 1.14B$ 1.02B$ 863.87M$ 791.46M$ 768.97M
Operating Expenses
$ 713.00M$ 771.11M$ 659.50M$ 886.39M$ 616.26M
Depreciation and Amortization
$ 223.57M$ 236.19M$ 229.40M$ 240.18M$ 233.41M
EBITDA
$ 603.87M$ 439.77M$ 500.78M$ 440.21M$ 401.10M
Operating Income
$ 423.09M$ 249.33M$ 204.37M$ -94.93M$ 152.72M
Other Income/Expenses
$ -283.88M$ -304.34M$ -244.64M$ -153.20M$ -121.35M
Pretax Income
$ 139.21M$ -55.01M$ -40.27M$ -248.13M$ 31.37M
Net Income
$ 72.06M$ -116.89M$ -83.99M$ -129.99M$ 10.62M
Per Share Metrics
Basic EPS
$ 0.23$ -0.38$ -0.48$ -0.86$ 0.07
Diluted EPS
$ 0.22$ -0.38$ -0.48$ -0.86$ 0.07
Weighted Average Shares Outstanding
 313.37M 308.98M 174.99M 150.94M 148.92M
Weighted Average Shares Outstanding (Diluted)
 324.81M 308.98M 176.14M 150.94M 151.82M
Currency in USD

Amneal Pharmaceuticals Earnings and Revenue History